Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ligands of brain nACh receptors designed at NeuroSearch

June 7, 1999

GDNF gene therapy approach to cerebrovascular disorders proven effective

June 4, 1999

Kinase inhibitor provides neuroprotection in focal cerebral ischemia

June 4, 1999

BASF discloses serotonergic agents for depression

June 4, 1999

New treatment for ALS available for licensing from Cornell Research Foundation

June 4, 1999

Repligen acquires additional capital for secretin trials in autism

June 3, 1999

Novel growth factor from GDNF-neurturin family identified by Washington U. researchers

June 3, 1999

Sonata launched in Germany

June 3, 1999

Opioid analgesics related to enkephalin prepared at Suntory

June 2, 1999

Cerebrus licenses AD drug from SmithKline Beecham

June 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...